Pterostilbene and Skin Aging: What Recent Research Reveals About Cellular Senescence

Pterostilbene has been studied in skin research for its antioxidant and anti-aging potential. Recent work is making the research picture more specific, particularly around dermal fibroblasts, mitochondrial function and cellular senescence.

Three studies published in 2025 provide a useful snapshot of this development. One investigated Pterostilbene in human dermal fibroblasts under UVB-induced and replicative senescence models. Another examined UVA-exposed sebocytes and fibroblasts. A third evaluated a 0.1% Pterostilbene skincare emulsion in a 28-day clinical study.

Featured Ingredient

Pterostilbene

Specs & COA Free Sample

Rather than treating these studies as proof of a single anti-aging mechanism, it is more useful to look at how they connect—and where the evidence still stops.

Why Cellular Senescence Is Relevant to Skin Aging

Skin aging involves changes in the extracellular matrix, oxidative stress, mitochondrial function and cellular activity. Dermal fibroblasts are central to this process because they produce and maintain collagen and other components of the dermal matrix.

Cellular senescence is one of the biological states being investigated in this context. Senescent cells show persistent changes in proliferation and cellular function, and senescence-associated changes have been linked with age-related tissue dysfunction.

Mitochondria are part of this picture because they regulate cellular energy production as well as redox balance and stress responses. Declining mitochondrial quality can therefore accompany cellular dysfunction.

This provides a more useful framework for studying Pterostilbene than antioxidant activity alone. Instead of asking only whether the compound reduces reactive oxygen species, researchers can examine whether it changes the cellular conditions associated with fibroblast aging.

What Recent Pterostilbene Research Found

A study published in Frontiers in Pharmacology in December 2025 investigated Pterostilbene in human dermal fibroblasts using UVB-induced acute oxidative stress and replicative senescence models. The researchers assessed senescence-associated β-galactosidase, p16 and p21, collagen expression and several measures of mitochondrial function. They also tested topical Pterostilbene in a UVB-exposed mouse model (Zhou et al., 2025).

In both fibroblast models, Pterostilbene was associated with lower SA-β-gal activity and reduced p16 and p21 levels, alongside increased collagen I and III expression. The treated cells also showed improvements in mitochondrial morphology and membrane potential, lower mitochondrial ROS, and higher basal respiration, ATP production and maximal respiration. Increased TOM20/LC3 colocalization was interpreted as enhanced mitophagy. In the mouse model, topical Pterostilbene was associated with restored collagen and dermal thickness and reduced p21 expression.

The significance of this study lies in the connection between these findings. Pterostilbene was not being evaluated only for its ability to control oxidative stress; the researchers linked mitochondrial quality control with senescence-associated changes in dermal fibroblasts.

That makes mitochondrial quality an interesting area for further Pterostilbene research. It does not, however, establish that topical Pterostilbene can reverse cellular senescence in human skin. The fibroblast experiments were conducted in vitro, while the in vivo work used mice.

A second 2025 study, published in the International Journal of Cosmetic Science, looked at a different aspect of skin aging. In UVA-exposed sebocytes, Pterostilbene reduced ROS and increased lipid synthesis. In UVA-exposed fibroblasts, it reduced ROS and increased collagen I and III. The study also reported changes in F-actin distribution and the expression of genes including Nrf2 and Sirt6 (Zhong et al., 2025).

This study broadens the research beyond dermal fibroblast senescence. It suggests that Pterostilbene may influence both sebaceous gland and dermal responses to UV-related stress, although these findings also come from experimental models rather than long-term human intervention.

From Cellular Findings to Human Skin Outcomes

The more difficult question is whether these biological observations can be connected with measurable changes in human skin.

A 2025 clinical study evaluated a skincare emulsion containing 0.1% Pterostilbene in 31 participants. The trial used a double-blind, split-face design over 28 days and compared the Pterostilbene emulsion with a control emulsion. Measurements included skin elasticity and firmness, wrinkle parameters, epidermal thickness, collagen-related fluorescence, elastic-fiber fluorescence and the dermal-epidermal junction (Cen et al., 2025).

The researchers reported significant improvements in several of these parameters compared with the control emulsion, including elasticity, firmness, wrinkle measurements, epidermal thickness and imaging-related collagen and elastic-fiber measures.

This gives Pterostilbene a human clinical data point that complements the laboratory research. It does not establish that the clinical changes were caused specifically by changes in cellular senescence or mitochondrial quality, because those mechanisms were not directly measured in the clinical study.

The study also has limitations that matter when interpreting the result. It involved 31 participants and lasted 28 days, and the tested material was one specific 0.1% Pterostilbene emulsion. In addition, the research was funded by Guangzhou Luanying Cosmetics Co., Ltd., and several authors were employed by the company or related organizations.

For Pterostilbene human studies, these details are important. The results are relevant, but they represent an early clinical data point rather than a complete body of evidence for long-term skin aging.

What This Means for Cosmetic Active Development

The recent research changes the development question slightly.

Pterostilbene can now be investigated through several connected endpoints: oxidative stress, fibroblast senescence, mitochondrial function, collagen-related responses and measurable skin parameters. These endpoints do not need to be treated as separate claims. Together, they can help build a more coherent picture of how an active behaves from biological testing through product evaluation.

For formulators, however, laboratory activity is only one part of that process.

The 0.1% clinical study was conducted with a defined emulsion and application protocol. Its results cannot simply be transferred to another concentration or formulation system. Solubility, stability, vehicle composition, processing and skin exposure may all affect the performance of Pterostilbene in a finished product.

This is where ingredient research and formulation development meet. A promising biological profile can justify further development, but the final assessment still depends on whether the ingredient performs consistently in a practical formulation and whether that performance can be supported by human data.

What the Current Evidence Still Needs

The recent Pterostilbene literature is becoming more interesting, but it is still relatively early.

The December 2025 fibroblast study provides a detailed experimental link between Pterostilbene, mitochondrial quality and senescence-associated changes. The UVA study adds evidence from sebocytes and fibroblasts exposed to environmental stress. The clinical study provides an initial human result using a 0.1% topical emulsion.

What remains unclear is how well these findings hold across longer periods of topical use and different formulation systems. Larger controlled clinical studies would also help determine whether the observed changes remain consistent over time.

For cosmetic R&D, that may be more useful than adding another mechanism to the list. A useful next step for Pterostilbene research is to establish which biological changes are reproducibly associated with meaningful, sustained changes in human skin, rather than simply adding more molecular markers to the evidence base.

That distinction will matter if Pterostilbene moves further into discussions around skin aging and longevity.

References